Loading...
Last submissions
-
Simon Baldacci, Benjamin Besse, Virginie Avrillon, Bertrand Mennecier, Julien Mazieres, et al.. Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort. European Journal of Cancer, 2022, 166, pp.51-59. ⟨10.1016/j.ejca.2022.01.018⟩. ⟨hal-04728569⟩
-
Mathieu Chalouni, Paul Loubet, Edouard Lhomme, Laetitia Ninove, Benoit Barrou, et al.. Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants. BMC Infectious Diseases, 2024, 24 (1049), ⟨10.1186/s12879-024-09861-5⟩. ⟨hal-04724620⟩
-
J. Guigay, C. Ortholan, D. Vansteene, D. Cupissol, C. Even, et al.. Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial. The Lancet. Healthy longevity, 2024, 5 (3), pp.e182--e193. ⟨10.1016/s2666-7568(23)00284-2⟩. ⟨hal-04661312⟩
-
Joël Guigay, Hervé Le Caer, François-Régis Ferrand, Lionel Geoffrois, Esma Saada-Bouzid, et al.. Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial. The Lancet. Healthy longevity, 2024, 5 (6), pp.e392-e405. ⟨10.1016/S2666-7568(24)00048-5⟩. ⟨hal-04578230⟩
-
Francois Gouin, Audrey Michot, Mehrdad Jafari, Charles Honoré, Jean Camille Mattei, et al.. Improved metastatic-free survival after systematic re-excision following complete macroscopic unplanned excision of limb or trunk soft tissue sarcoma. Cancers, 2024, 16 (7), pp.1365. ⟨10.3390/cancers16071365⟩. ⟨hal-04653665⟩
-
Pierre-Emmanuel Colombo, Marine Lefevre, Laure Delmond, Drissa Traore, William Jacot, et al.. Oncoplastic Resection of Breast Cancers Located in the Lower-Inner or Lower-Outer Quadrant with the Modified McKissock Mammaplasty Technique. Annals of Surgical Oncology, 2015, 22 (S3), pp.486 - 494. ⟨10.1245/s10434-015-4727-5⟩. ⟨hal-01913732⟩
-
Owen Zacarias, Cristina Clement, Shu-Yuan Cheng, Melissa Rosas, Christina Gonzalez, et al.. Mitomycin C and its analog trigger cytotoxicity in MCF-7 and K562 cancer cells through the regulation of RAS and MAPK/ERK pathways. Chemico-Biological Interactions, 2024, 395, pp.111007. ⟨10.1016/j.cbi.2024.111007⟩. ⟨hal-04762226⟩
-
Gunjan Kayal, Nathaly Barbosa, Carlos Calderón Marín, Ludovic Ferrer, José-Alejandro Fragoso-Negrín, et al.. Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study. Journal of Nuclear Medicine, 2024, 65 (1), pp.125-131. ⟨10.2967/jnumed.122.265340⟩. ⟨hal-04753484⟩
-
Gilles Boni, Vincent Placet, Marina Grimaldi, Patrick Balaguer, Sylvie Pourchet. Toward the manufacturing of a non-toxic high-performance biobased epoxy–hemp fibre composite. Polymers, 2024, Advances in the Processing and Application of Polymers and Their Composites III, 16, pp.2010 (15). ⟨10.3390/polym16142010⟩. ⟨hal-04745627⟩
-
Sarah Figarol, Célia Delahaye, Rémi Gence, Aurélia Doussine, Juan Pablo Cerapio, et al.. Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies. Nature Communications, 2024, 15 (1), pp.5345. ⟨10.1038/s41467-024-49360-4⟩. ⟨hal-04727333⟩